Currently out of the existing stock ratings of Alec Stranahan, 21 are a BUY (52.5%), 12 are a HOLD (30%), 7 are a SELL (17.5%).

Alec Stranahan

Work Performance Price Targets & Ratings Chart

Analyst Alec Stranahan, currently employed at BAML, carries an average stock price target met ratio of 51.02% that have a potential upside of 29.09% achieved within 208 days.

Alec Stranahan’s has documented 80 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ERAS, Erasca at 03-Sep-2025.

Wall Street Analyst Alec Stranahan

Analyst best performing recommendations are on TGTX (TG THERAPEUTICS).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS) at 5/20/2022. The price target of $5 was fulfilled within 4 days with a profit of $0.39 (7.24%) receiving and performance score of 18.09.

Average potential price target upside

of $36.61 (52.23%) on KRYS (KRYSTAL BIOTECH).
of $15.36 (54.72%) on SWTX (SPRINGWORKS THERAPEUTICS).
of $8.37 (36.04%) on NXTC (NEXTCURE ).

NXTC NextCure KRYS Krystal Biotech NVAX Novavax TGTX TG Therapeutics YMAB Y mAbs Therapeutics DAWN Day One Biopharmaceuticals RVMD Revolution Medicines MGTX MeiraGTx Holdings PLC ERAS Erasca SWTX SpringWorks Therapeutics CATX Perspective Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Edward Tenthoff (PIPER SANDLER)